Clinical Trial Update: Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 study evaluating sirolimus in combination with cyclosporine for kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Renal Transplantation | Phase 3 | Status: COMPLETED